Asep Medical Holdings Inc. is a healthcare company specializing in the development of innovative diagnostic and therapeutic solutions focused on the treatment of sepsis, a severe and potentially life-threatening condition caused by infection. The company leverages advanced peptide technologies to address bacterial biofilm infections, which are notably resistant to conventional treatments, as well as anti-inflammatory and immune-modulating therapies. In addition to therapeutics, Asep Medical Holdings offers diagnostic kits designed to predict the onset of severe sepsis and related organ failures, and produces specialized coatings for medical devices to reduce infection risks. Established in 2021 and headquartered in Victoria, British Columbia, Canada, Asep Medical Holdings operates within the health care equipment sector, targeting substantial global markets linked to antibiotic resistance and sepsis diagnosis and treatment. Its portfolio combines both diagnostic and therapeutic intellectual property, positioning the company as a player addressing significant unmet medical needs in infection-related healthcare.